PharmiWeb.com - Global Pharma News & Resources
03-Sep-2018

Trading in Novo Nordisk shares by board members, executives and associated persons on 31 August 2018

Bagsværd, Denmark, 3 September 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.


The company's board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company's board members, executives and their associated persons.

Further information

Media:    
Katrine Sperling+45 4442 6718 krsp@novonordisk.com
Ken Inchausti (US)+1 609 786 8316 kiau@novonordisk.com
     
Investors :    
Peter Hugreffe Ankersen+45 3075 9085 phak@novonordisk.com
Anders Mikkelsen+45 3079 4461 armk@novonordisk.com
Valdemar Borum Svarrer+45 3079 0301 jvls@novonordisk.com  

Company announcement No 69 / 2018 Company announcement No 69/2018


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via GlobeNewswire
HUG#2213899

Editor Details

Last Updated: 04-Sep-2018